Global Aurora Kinase A Market Analysis and Forecast 2025-2031
Description
Summary
According to APO Research, The global Aurora Kinase A market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Aurora Kinase A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Aurora Kinase A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Aurora Kinase A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Aurora Kinase A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Aurora Kinase A include Sanofi, Merck & Co., Inc., Amgen Inc., AbbVie Inc., Vichem Chemie Research Ltd., Vertex Pharmaceuticals Incorporated, Taiho Pharmaceutical Co., Ltd., Sigma-Tau S.p.A. and Sareum Holdings Plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Aurora Kinase A, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Aurora Kinase A, also provides the sales of main regions and countries. Of the upcoming market potential for Aurora Kinase A, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Aurora Kinase A sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Aurora Kinase A market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Aurora Kinase A sales, projected growth trends, production technology, application and end-user industry.
Aurora Kinase A Segment by Company
Sanofi
Merck & Co., Inc.
Amgen Inc.
AbbVie Inc.
Vichem Chemie Research Ltd.
Vertex Pharmaceuticals Incorporated
Taiho Pharmaceutical Co., Ltd.
Sigma-Tau S.p.A.
Sareum Holdings Plc
Millennium Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Astex Pharmaceuticals, Inc.
Aurora Kinase A Segment by Type
AMG-900
Ilorasertib
ENMD-2076
Danusertib
Others
Aurora Kinase A Segment by Application
Brain Tumor
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Others
Aurora Kinase A Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase A and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase A.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Aurora Kinase A in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Aurora Kinase A manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aurora Kinase A sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Aurora Kinase A market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Aurora Kinase A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Aurora Kinase A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Aurora Kinase A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Aurora Kinase A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Aurora Kinase A include Sanofi, Merck & Co., Inc., Amgen Inc., AbbVie Inc., Vichem Chemie Research Ltd., Vertex Pharmaceuticals Incorporated, Taiho Pharmaceutical Co., Ltd., Sigma-Tau S.p.A. and Sareum Holdings Plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Aurora Kinase A, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Aurora Kinase A, also provides the sales of main regions and countries. Of the upcoming market potential for Aurora Kinase A, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Aurora Kinase A sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Aurora Kinase A market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Aurora Kinase A sales, projected growth trends, production technology, application and end-user industry.
Aurora Kinase A Segment by Company
Sanofi
Merck & Co., Inc.
Amgen Inc.
AbbVie Inc.
Vichem Chemie Research Ltd.
Vertex Pharmaceuticals Incorporated
Taiho Pharmaceutical Co., Ltd.
Sigma-Tau S.p.A.
Sareum Holdings Plc
Millennium Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Astex Pharmaceuticals, Inc.
Aurora Kinase A Segment by Type
AMG-900
Ilorasertib
ENMD-2076
Danusertib
Others
Aurora Kinase A Segment by Application
Brain Tumor
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Others
Aurora Kinase A Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase A and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase A.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Aurora Kinase A in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Aurora Kinase A manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aurora Kinase A sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
198 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Aurora Kinase A Market by Type
- 1.2.1 Global Aurora Kinase A Market Size by Type, 2020 VS 2024 VS 2031
- 1.2.2 AMG-900
- 1.2.3 Ilorasertib
- 1.2.4 ENMD-2076
- 1.2.5 Danusertib
- 1.2.6 Others
- 1.3 Aurora Kinase A Market by Application
- 1.3.1 Global Aurora Kinase A Market Size by Application, 2020 VS 2024 VS 2031
- 1.3.2 Brain Tumor
- 1.3.3 Ovarian Cancer
- 1.3.4 Anaplastic Large Cell Lymphoma
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Aurora Kinase A Market Dynamics
- 2.1 Aurora Kinase A Industry Trends
- 2.2 Aurora Kinase A Industry Drivers
- 2.3 Aurora Kinase A Industry Opportunities and Challenges
- 2.4 Aurora Kinase A Industry Restraints
- 3 Global Market Growth Prospects
- 3.1 Global Aurora Kinase A Revenue Estimates and Forecasts (2020-2031)
- 3.2 Global Aurora Kinase A Revenue by Region
- 3.2.1 Global Aurora Kinase A Revenue by Region: 2020 VS 2024 VS 2031
- 3.2.2 Global Aurora Kinase A Revenue by Region (2020-2025)
- 3.2.3 Global Aurora Kinase A Revenue by Region (2026-2031)
- 3.2.4 Global Aurora Kinase A Revenue Market Share by Region (2020-2031)
- 3.3 Global Aurora Kinase A Sales Estimates and Forecasts 2020-2031
- 3.4 Global Aurora Kinase A Sales by Region
- 3.4.1 Global Aurora Kinase A Sales by Region: 2020 VS 2024 VS 2031
- 3.4.2 Global Aurora Kinase A Sales by Region (2020-2025)
- 3.4.3 Global Aurora Kinase A Sales by Region (2026-2031)
- 3.4.4 Global Aurora Kinase A Sales Market Share by Region (2020-2031)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
- 4 Market Competitive Landscape by Manufacturers
- 4.1 Global Aurora Kinase A Revenue by Manufacturers
- 4.1.1 Global Aurora Kinase A Revenue by Manufacturers (2020-2025)
- 4.1.2 Global Aurora Kinase A Revenue Market Share by Manufacturers (2020-2025)
- 4.1.3 Global Aurora Kinase A Manufacturers Revenue Share Top 10 and Top 5 in 2024
- 4.2 Global Aurora Kinase A Sales by Manufacturers
- 4.2.1 Global Aurora Kinase A Sales by Manufacturers (2020-2025)
- 4.2.2 Global Aurora Kinase A Sales Market Share by Manufacturers (2020-2025)
- 4.2.3 Global Aurora Kinase A Manufacturers Sales Share Top 10 and Top 5 in 2024
- 4.3 Global Aurora Kinase A Sales Price by Manufacturers (2020-2025)
- 4.4 Global Aurora Kinase A Key Manufacturers Ranking, 2023 VS 2024 VS 2025
- 4.5 Global Aurora Kinase A Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Aurora Kinase A Manufacturers, Product Type & Application
- 4.7 Global Aurora Kinase A Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Aurora Kinase A Market CR5 and HHI
- 4.8.2 2024 Aurora Kinase A Tier 1, Tier 2, and Tier 3
- 5 Aurora Kinase A Market by Type
- 5.1 Global Aurora Kinase A Revenue by Type
- 5.1.1 Global Aurora Kinase A Revenue by Type (2020 VS 2024 VS 2031)
- 5.1.2 Global Aurora Kinase A Revenue by Type (2020-2031) & (US$ Million)
- 5.1.3 Global Aurora Kinase A Revenue Market Share by Type (2020-2031)
- 5.2 Global Aurora Kinase A Sales by Type
- 5.2.1 Global Aurora Kinase A Sales by Type (2020 VS 2024 VS 2031)
- 5.2.2 Global Aurora Kinase A Sales by Type (2020-2031) & (K Units)
- 5.2.3 Global Aurora Kinase A Sales Market Share by Type (2020-2031)
- 5.3 Global Aurora Kinase A Price by Type
- 6 Aurora Kinase A Market by Application
- 6.1 Global Aurora Kinase A Revenue by Application
- 6.1.1 Global Aurora Kinase A Revenue by Application (2020 VS 2024 VS 2031)
- 6.1.2 Global Aurora Kinase A Revenue by Application (2020-2031) & (US$ Million)
- 6.1.3 Global Aurora Kinase A Revenue Market Share by Application (2020-2031)
- 6.2 Global Aurora Kinase A Sales by Application
- 6.2.1 Global Aurora Kinase A Sales by Application (2020 VS 2024 VS 2031)
- 6.2.2 Global Aurora Kinase A Sales by Application (2020-2031) & (K Units)
- 6.2.3 Global Aurora Kinase A Sales Market Share by Application (2020-2031)
- 6.3 Global Aurora Kinase A Price by Application
- 7 Company Profiles
- 7.1 Sanofi
- 7.1.1 Sanofi Comapny Information
- 7.1.2 Sanofi Business Overview
- 7.1.3 Sanofi Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 Sanofi Aurora Kinase A Product Portfolio
- 7.1.5 Sanofi Recent Developments
- 7.2 Merck & Co., Inc.
- 7.2.1 Merck & Co., Inc. Comapny Information
- 7.2.2 Merck & Co., Inc. Business Overview
- 7.2.3 Merck & Co., Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Merck & Co., Inc. Aurora Kinase A Product Portfolio
- 7.2.5 Merck & Co., Inc. Recent Developments
- 7.3 Amgen Inc.
- 7.3.1 Amgen Inc. Comapny Information
- 7.3.2 Amgen Inc. Business Overview
- 7.3.3 Amgen Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Amgen Inc. Aurora Kinase A Product Portfolio
- 7.3.5 Amgen Inc. Recent Developments
- 7.4 AbbVie Inc.
- 7.4.1 AbbVie Inc. Comapny Information
- 7.4.2 AbbVie Inc. Business Overview
- 7.4.3 AbbVie Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 AbbVie Inc. Aurora Kinase A Product Portfolio
- 7.4.5 AbbVie Inc. Recent Developments
- 7.5 Vichem Chemie Research Ltd.
- 7.5.1 Vichem Chemie Research Ltd. Comapny Information
- 7.5.2 Vichem Chemie Research Ltd. Business Overview
- 7.5.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio
- 7.5.5 Vichem Chemie Research Ltd. Recent Developments
- 7.6 Vertex Pharmaceuticals Incorporated
- 7.6.1 Vertex Pharmaceuticals Incorporated Comapny Information
- 7.6.2 Vertex Pharmaceuticals Incorporated Business Overview
- 7.6.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio
- 7.6.5 Vertex Pharmaceuticals Incorporated Recent Developments
- 7.7 Taiho Pharmaceutical Co., Ltd.
- 7.7.1 Taiho Pharmaceutical Co., Ltd. Comapny Information
- 7.7.2 Taiho Pharmaceutical Co., Ltd. Business Overview
- 7.7.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio
- 7.7.5 Taiho Pharmaceutical Co., Ltd. Recent Developments
- 7.8 Sigma-Tau S.p.A.
- 7.8.1 Sigma-Tau S.p.A. Comapny Information
- 7.8.2 Sigma-Tau S.p.A. Business Overview
- 7.8.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio
- 7.8.5 Sigma-Tau S.p.A. Recent Developments
- 7.9 Sareum Holdings Plc
- 7.9.1 Sareum Holdings Plc Comapny Information
- 7.9.2 Sareum Holdings Plc Business Overview
- 7.9.3 Sareum Holdings Plc Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 Sareum Holdings Plc Aurora Kinase A Product Portfolio
- 7.9.5 Sareum Holdings Plc Recent Developments
- 7.10 Millennium Pharmaceuticals, Inc.
- 7.10.1 Millennium Pharmaceuticals, Inc. Comapny Information
- 7.10.2 Millennium Pharmaceuticals, Inc. Business Overview
- 7.10.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.10.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
- 7.10.5 Millennium Pharmaceuticals, Inc. Recent Developments
- 7.11 CASI Pharmaceuticals Inc.
- 7.11.1 CASI Pharmaceuticals Inc. Comapny Information
- 7.11.2 CASI Pharmaceuticals Inc. Business Overview
- 7.11.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.11.4 CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio
- 7.11.5 CASI Pharmaceuticals Inc. Recent Developments
- 7.12 Astex Pharmaceuticals, Inc.
- 7.12.1 Astex Pharmaceuticals, Inc. Comapny Information
- 7.12.2 Astex Pharmaceuticals, Inc. Business Overview
- 7.12.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.12.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
- 7.12.5 Astex Pharmaceuticals, Inc. Recent Developments
- 8 North America
- 8.1 North America Aurora Kinase A Market Size by Type
- 8.1.1 North America Aurora Kinase A Revenue by Type (2020-2031)
- 8.1.2 North America Aurora Kinase A Sales by Type (2020-2031)
- 8.1.3 North America Aurora Kinase A Price by Type (2020-2031)
- 8.2 North America Aurora Kinase A Market Size by Application
- 8.2.1 North America Aurora Kinase A Revenue by Application (2020-2031)
- 8.2.2 North America Aurora Kinase A Sales by Application (2020-2031)
- 8.2.3 North America Aurora Kinase A Price by Application (2020-2031)
- 8.3 North America Aurora Kinase A Market Size by Country
- 8.3.1 North America Aurora Kinase A Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 8.3.2 North America Aurora Kinase A Sales by Country (2020 VS 2024 VS 2031)
- 8.3.3 North America Aurora Kinase A Price by Country (2020-2031)
- 8.3.4 United States
- 8.3.5 Canada
- 9 Europe
- 9.1 Europe Aurora Kinase A Market Size by Type
- 9.1.1 Europe Aurora Kinase A Revenue by Type (2020-2031)
- 9.1.2 Europe Aurora Kinase A Sales by Type (2020-2031)
- 9.1.3 Europe Aurora Kinase A Price by Type (2020-2031)
- 9.2 Europe Aurora Kinase A Market Size by Application
- 9.2.1 Europe Aurora Kinase A Revenue by Application (2020-2031)
- 9.2.2 Europe Aurora Kinase A Sales by Application (2020-2031)
- 9.2.3 Europe Aurora Kinase A Price by Application (2020-2031)
- 9.3 Europe Aurora Kinase A Market Size by Country
- 9.3.1 Europe Aurora Kinase A Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 9.3.2 Europe Aurora Kinase A Sales by Country (2020 VS 2024 VS 2031)
- 9.3.3 Europe Aurora Kinase A Price by Country (2020-2031)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 10 China
- 10.1 China Aurora Kinase A Market Size by Type
- 10.1.1 China Aurora Kinase A Revenue by Type (2020-2031)
- 10.1.2 China Aurora Kinase A Sales by Type (2020-2031)
- 10.1.3 China Aurora Kinase A Price by Type (2020-2031)
- 10.2 China Aurora Kinase A Market Size by Application
- 10.2.1 China Aurora Kinase A Revenue by Application (2020-2031)
- 10.2.2 China Aurora Kinase A Sales by Application (2020-2031)
- 10.2.3 China Aurora Kinase A Price by Application (2020-2031)
- 11 Asia (Excluding China)
- 11.1 Asia Aurora Kinase A Market Size by Type
- 11.1.1 Asia Aurora Kinase A Revenue by Type (2020-2031)
- 11.1.2 Asia Aurora Kinase A Sales by Type (2020-2031)
- 11.1.3 Asia Aurora Kinase A Price by Type (2020-2031)
- 11.2 Asia Aurora Kinase A Market Size by Application
- 11.2.1 Asia Aurora Kinase A Revenue by Application (2020-2031)
- 11.2.2 Asia Aurora Kinase A Sales by Application (2020-2031)
- 11.2.3 Asia Aurora Kinase A Price by Application (2020-2031)
- 11.3 Asia Aurora Kinase A Market Size by Country
- 11.3.1 Asia Aurora Kinase A Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 11.3.2 Asia Aurora Kinase A Sales by Country (2020 VS 2024 VS 2031)
- 11.3.3 Asia Aurora Kinase A Price by Country (2020-2031)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
- 12 South America, Middle East and Africa
- 12.1 SAMEA Aurora Kinase A Market Size by Type
- 12.1.1 SAMEA Aurora Kinase A Revenue by Type (2020-2031)
- 12.1.2 SAMEA Aurora Kinase A Sales by Type (2020-2031)
- 12.1.3 SAMEA Aurora Kinase A Price by Type (2020-2031)
- 12.2 SAMEA Aurora Kinase A Market Size by Application
- 12.2.1 SAMEA Aurora Kinase A Revenue by Application (2020-2031)
- 12.2.2 SAMEA Aurora Kinase A Sales by Application (2020-2031)
- 12.2.3 SAMEA Aurora Kinase A Price by Application (2020-2031)
- 12.3 SAMEA Aurora Kinase A Market Size by Country
- 12.3.1 SAMEA Aurora Kinase A Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 12.3.2 SAMEA Aurora Kinase A Sales by Country (2020 VS 2024 VS 2031)
- 12.3.3 SAMEA Aurora Kinase A Price by Country (2020-2031)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
- 13 Value Chain and Sales Channels Analysis
- 13.1 Aurora Kinase A Value Chain Analysis
- 13.1.1 Aurora Kinase A Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Aurora Kinase A Production Mode & Process
- 13.2 Aurora Kinase A Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Aurora Kinase A Distributors
- 13.2.3 Aurora Kinase A Customers
- 14 Concluding Insights
- 15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



